Boston Scientific voluntarily recalls the Chariot guiding sheath

Boston Scientific announced on Dec. 9 that it had voluntarily recalled its Chariot guiding sheath after receiving 14 complaints of shaft separation. The FDA classified it as a Class 1 recall, which is the most serious type of recall.

The Chariot guiding sheath is used to introduce interventional devices during peripheral vascular procedures. Of the 14 complaints, four involved shaft separation during device preparation or use.

If the shaft separates, it could lead to embolism of the device fragments and obstruction of blood flow or additional intervention to remove a device fragment. If the blood flow is obstructed, patients may have severe injuries such as stroke, kidney damage or damage to the intestine or limbs. No permanent injuries or deaths have been reported, according to Boston Scientific.

The company said in a news release that healthcare facilities should immediately discontinue use of affected devices and physicians should contact patients who have undergone procedures with the Chariot guiding sheath to confirm their status.

On Nov. 27, the FDA announced Boston Scientific had recalled its RotaWire Elite Guidewires and wireClip Torquer Guidewires after receiving three reports of the wires cracking and separating from the Rotablator Rotational Atherectomy System.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.